GSK to set up biotechnology centre
GlaxoSmithKline is partnering with the UK government and the Wellcome Trust to develop a biotechnology science park located at the pharmaceutical company’s Stevenage site.

GlaxoSmithKline (GSK) is partnering with the
government and the Wellcome Trust to develop a biotechnology science park located at the pharmaceutical company’s
site.
The funding for the park, which is estimated at £38m, is being led by East of England Development Agency (EEDA).
GSK claims that the park could be an international hub for early-stage biotechnology companies. It is hoped that the campus will compete with those in
It is anticipated that, when complete, the new centre will be the base for approximately 1,500 scientists. GSK believes that any company located in the park will have shared access to specialist skills, equipment and expertise to stimulate innovation in drug development, increasing the chance of success.
‘The Stevenage Campus will affirm the
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
Radio wave weapon knocks out drone swarms
Probably. A radio-controlled drone cannot be completely shielded to RF, else you´d lose the ability to control it. The fibre optical cable removes...